0.05Open0.05Pre Close0 Volume120 Open Interest24.00Strike Price0.00Turnover8624.01%IV36.18%PremiumOct 4, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0432Delta0.0305Gamma353.20Leverage Ratio-91.3412Theta0.0000Rho15.27Eff Leverage0.0000Vega
Hims & Hers Health Stock Discussion
nailed it
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
$Cloudflare (NET.US)$ $Hims & Hers Health (HIMS.US)$ $DocuSign (DOCU.US)$ $Invesco QQQ Trust (QQQ.US)$
No comment yet